New York Presbyterian Hospital (Site 1046) — New York, New York

New York Presbyterian Hospital (Site 1046) is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Presbyterian Hospital (Site 1046) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian Hospital (Site 1046)?

New York Presbyterian Hospital (Site 1046) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian Hospital (Site 1046) conducted?

New York Presbyterian Hospital (Site 1046) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is New York Presbyterian Hospital (Site 1046) accredited by Crixeo Health?

New York Presbyterian Hospital (Site 1046) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Presbyterian Hospital (Site 1046)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.